Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin with neoadjuvant chemotherapy in breast cancer
IRCT20200409047007N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in breast cancer, sponsored by Mashhad University of Medical Sciences. Primary endpoint: Pathological response in breast cancer. Started Dec 2021; status: completed.
02
Drugs
melatonin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20200409047007N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200409047007N3.